Kyverna Therapeutics Cash Flow Statement (2023-2026) | KYTX

Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -11.14M-13.08M-15.45M-20.64M-26.67M-28.78M-34.45M-37.49M-44.61M-42.06M-36.73M-37.82M-39.71M
Share-based Compensation (Quarter) 0.47M0.45M0.52M0.78M2.28M1.28M3.41M1.38M2.16M2.52M2.70M2.70M3.17M
Gains from Sales and Divestitures (Quarter) 0.04M0.08M0.10M0.08M
Gains from Investment Securities (Quarter) 0.17M0.19M0.10M0.58M4.23M0.01M0.10M0.30M0.69M9.94M3.95M0.84M0.43M
Asset Writedowns and Impairment (Quarter) 0.65M
Non-cash Items (Quarter) 11.81M1.72M12.63M1.85M0.76M1.81M2.16M16.12M43.82M2.92M
Cash from Operations (Quarter) -11.46M-11.26M-11.13M-18.55M-25.52M-24.18M-27.49M-37.11M-44.90M-31.96M-43.32M-33.52M-41.60M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.08M-0.01M0.44M0.60M0.28M2.25M2.89M2.24M2.11M1.84M1.57M1.37M0.73M
Depreciation & Amortization (CF) (Quarter) 0.39M0.41M0.44M0.46M0.48M0.53M0.56M0.56M0.50M0.52M0.41M0.37M0.35M
Change in Working Capital
Change in Account Payables (Quarter) 0.10M0.49M0.51M2.98M3.07M-2.10M5.07M-5.30M3.78M1.41M-6.80M-0.89M6.28M
Change in Accured Expenses (Quarter) -0.78M0.50M0.72M0.96M-1.45M1.36M1.72M0.44M-1.80M1.89M1.99M3.03M-6.88M
Other Working Capital Changes (Quarter) -0.34M-0.43M-0.44M-0.46M-0.52M-0.01M0.00M-2.69M0.05M0.20M0.36M-0.84M-0.50M
Investing Activities
Capital Expenditures (Quarter) 0.03M-0.01M0.26M0.33M0.54M-0.54M1.67M0.53M0.00M-0.00M0.01M
Change in Acquisitions & Divestments (Quarter) 13.68M33.00M23.00M13.00M138.30M157.00M86.70M124.10M95.70M99.20M65.70M
Cash from Investing Activities (Quarter) 13.65M-0.00M-54.12M31.68M-122.88M-67.92M0.68M29.22M5.58M29.17M22.56M-17.29M-50.20M
Financing Activities
Other financing activities (Quarter) 1.49M2.96M0.41M0.08M0.34M0.06M0.07M
Cash from Financing Activities (Quarter) -0.14M24.91M34.79M-1.43M338.05M-0.57M-0.15M-0.21M-0.41M-0.65M1.49M140.74M-0.10M
Additional items
Change in Cash (Quarter) 2.05M13.65M-30.46M11.68M189.65M-92.67M-26.96M-8.05M-39.75M-3.43M-19.28M89.93M-91.90M
Free Cash Flow (Quarter) -11.49M-11.25M-11.40M-18.89M-26.07M-23.63M-29.16M-37.64M-44.90M-31.97M-43.32M-33.52M-41.60M
Net Cash Flow (Quarter) 2.05M13.65M-30.46M11.69M189.65M-92.67M-26.96M-8.10M-39.74M-3.45M-19.28M89.94M-91.90M